Lectin binding patterns of alveolar epithelium and subepithelial seromucous glands of the bronchi in sepsis and controls--an approach to characterize the non-specific immunological response of the human lung to sepsis.
A delayed or deficient immunological protection as well as an overstimulation of the mucosal immune system may act as possible additional promoters of sepsis-induced lung injury in patients suffering from a severe septic condition. Lectin-binding patterns in pulmonary tissue samples obtained at autopsy from septic patients and control individuals were studied using 11 carbohydrate-specific lectins (Con A, UEA, GSA I, GSA II, MPA, PNA, Jac, WGA, MAA, LPA, and SNA). There were no differences in the secretory product of serous parts of bronchial glands detectable in the two study groups, whereas lectin binding patterns of alveolar epithelium and mucous parts of subepithelial seromucous glands were different in sepsis cases when compared to controls. Apart from differences in binding sites for alpha-mannose, N-acetyl-neuraminic acid and alpha-(2-6)-galactose (as detected by different expression for Con A, MAA and SNA) in the two study groups, the main finding was that no binding sites for alpha-N-acetyl-galactosamine (as investigated by MPA immunoreactivity) could be detected on alveolar epithelial cells and mucous parts of subepithelial seromucous glands in sepsis cases in contrast to the presence of such binding sites in the control cases. We hypothesize that the finding of an altered secretory product of alveolar epithelial cells and bronchial glands in sepsis may be a result of specific carbohydrate deprivation or consumption, respectively, possibly due to direct bacterial effects or pathogenetic events in response to bacterial toxins during the complex cascade of the host's systemic inflammatory response in sepsis. The altered type of mucus glycoprotein physiologically secreted by alveolar epithelium and mucous parts of subepithelial seromucous glands of the bronchi with subsequent loss of a considerable proportion of protection of the mucosal barrier in sepsis may play an important additional role in the development of sepsis-induced lung injury.
Tsokos
M
M
Institute of Legal Medicine, University of Hamburg, Butenfeld 34, 22529 Hamburg, Germany, Germany.
Anders
S
S
Institute of Legal Medicine, University of Hamburg, Butenfeld 34, 22529 Hamburg, Germany, Germany.|Institute of Pathology, University of Hamburg, Martinistrasse 52, 20246 Hamburg, Germany, Germany.
Paulsen
F
F
Department of Anatomy, Christians-Albrechts-University of Kiel, Olshausenstrasse 40, 24098 Kiel, Germany, Germany.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001665:Binding Sites; D001980:Bronchi / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D004848:Epithelium / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D005088:Exocrine Glands / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D005260:Female; D020397:Goblet Cells / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D006801:Humans; D037102:Lectins / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D011650:Pulmonary Alveoli / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D012128:Respiratory Distress Syndrome / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D018805:Sepsis / Q000276:immunology / Q000378:metabolism* / Q000473:pathology
D037102:Lectins